MENU
PEN
AS OF
Feb 4, 12:07 PM (EDT)
Price
$343.51
Change
-$12.49 (-3.51%)
Capitalization
13.97B
20 days until earnings call
Intraday BUY SELL Signals
+Compare
PEN
Stock ticker: NYSE
AS OF
Feb 4, 12:07 PM (EDT)
Price
$343.51
Change
-$12.49 (-3.51%)
Capitalization
13.97B

PEN Penumbra Forecast, Technical & Fundamental Analysis

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots... Show more

PEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PEN with price predictions
Feb 03, 2026

Aroon Indicator for PEN shows an upward move is likely

PEN's Aroon Indicator triggered a bullish signal on January 16, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 237 similar instances where the Aroon Indicator showed a similar pattern. In of the 237 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 15, 2026. You may want to consider a long position or call options on PEN as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PEN moved out of overbought territory on February 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where PEN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PEN turned negative on February 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PEN broke above its upper Bollinger Band on January 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.277) is normal, around the industry mean (11.546). P/E Ratio (84.964) is within average values for comparable stocks, (38.420). Projected Growth (PEG Ratio) (0.817) is also within normal values, averaging (1.636). PEN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (10.593) is also within normal values, averaging (38.937).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PEN is expected to report earnings to rise 13.40% to $1.10 per share on February 24

Penumbra PEN Stock Earnings Reports
Q4'25
Est.
$1.10
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.07
The last earnings report on November 05 showed earnings per share of 97 cents, beating the estimate of 92 cents. With 1.11M shares outstanding, the current market capitalization sits at 13.97B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Penumbra Place
Phone
+1 510 748-3200
Employees
4200
Web
https://www.penumbrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ICOW41.600.48
+1.17%
Pacer Dev Mkts Intl Csh Cows 100 ETF
OGSP10.04N/A
N/A
Obra High Grade Structured Products ETF
RFEM85.65-0.01
-0.01%
First Trust RiverFront Dyn Em Mkts ETF
ZECP35.58-0.16
-0.45%
Zacks Earnings Consistent ETF
ASMG37.19-2.40
-6.06%
Leverage Shares 2X Long Asml Daily ETF

PEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with BSX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-0.33%
BSX - PEN
45%
Loosely correlated
-1.77%
PODD - PEN
43%
Loosely correlated
+0.32%
ISRG - PEN
42%
Loosely correlated
-1.49%
ITGR - PEN
38%
Loosely correlated
-1.51%
AVNS - PEN
37%
Loosely correlated
+1.13%
More

Groups containing PEN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-0.33%
Medical/Nursing Services
industry (216 stocks)
14%
Poorly correlated
-0.81%
Health Services
industry (410 stocks)
5%
Poorly correlated
-0.91%